MyMD Pharmaceuticals Inc (MYMD)

[BioFan1]

OK, folks, not sure how many follow this board or care, but I do want the pleasure of saying "I told you so" next year. What the hell is sarcopenia, you ask, and why make a drug for it? Here's a headline from 2017:

The CDC recently recognized sarcopenia as a reportable medical condition necessitating better screening and diagnosis of this geriatric syndrome. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576154/

CDC recognition means the treatment can now be medically diagnosed, treated and, most importantly, billed! And it has its very own ICD-10 billing code. Sarcopenia article

Excerpt from the article: "Recently, there has been a call to action to systematically address sarcopenia by interdisciplinary organizations such as the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Working Group on Sarcopenia (IWGS).4,5 This call to action is due to the association of sarcopenia with increased health care costs, higher disability incidence, and elevated risk of mortality.6,7 The consequences of sarcopenia may include serious complications, such as hip fracture or a loss of functional independence. 8,9 The CDC now recognizes sarcopenia as an independently reportable medical condition. Consequently, physicians, nurse practitioners (NPs), and other associated health professionals within the VA will need to better understand clinically viable and valid methods to screen and diagnose this geriatric syndrome."

As of today, there are NO approved drugs for this newly recognized condition that affects millions. So, MYMD-1 will launch as the only FDA-approved drug that physicians can prescribe for this condition. And it happens to be safe, with none of the toxicity in other TNF alpha blockers that no doctor in his right mind would prescribe for sarcopenia. In other words, a virtual monopoly on treatment of this widespread condition. Not to mention the other indications to follow, like arthritis, MS, and other inflammatory diseases.

MYMD is on sale these days, like a lot a biotech startups. You can thank me later.